Vision · Focus · Scope

The Egg Factory Vision:

"To be recognized by the business community as the leading independent supplier of substantial and/or transformational proprietary innovations with significant current commercial appeal."

The Egg Factory grew out of an innovative vision that Dr. Ronald Blum, the President and CEO of the Company, had in 1998. Since that time, The Egg Factory has been transformed into an operational company.

In March of 1996, Dr. Blum took the company he founded in 1990, Innotech, Inc., public on the NASDAQ. In March of 1997, Johnson and Johnson, Inc. purchased the company. Immediately following the sale in 1997, Dr. Blum spent a significant amount of time analyzing the elements of Innotech's success.

The Egg Factory is the vision that was born out of this in depth analysis. Dr. Blum concluded that many Fortune 500 companies need to acquire innovations in order to maintain shareholder value through top and bottom line growth. Therefore, the idea of a company was conceived that could consistently supply proprietary innovations to major corporations.

Dr. Blum believes that one of the key factors contributing to the success of Innotech was the talented management team he was able to attract. Dr. Blum believes he has once again been able to attract and surround himself with an extremely talented and experienced management team, Board of Managers and Technology Advisory Board for the Company.

The Egg Factory Focus:

The Company is focused on developing substantial and transformational innovations, not incremental innovations, and selling and/or licensing these innovations to global companies. In addition, the Company focuses on embryonic and early stage concepts, while avoiding mature stage concepts. The Company believes that substantial and transformational innovation originated at an embryonic or early stage possesses the highest degree of risk, but also provides the Company with the ability to shape and control the opportunity, increasing the probability of success, while at the same time having the greatest potential for high rewards.

The Company believes there are three levels of innovation:

• Incremental Innovation:
  Incremental innovation involves the continuous improvement of existing products or systems in order to meet customers' needs.
  
  
• Substantial Innovation:
  Substantial innovation involves a constant direction but results in big improvements to an existing product or system. Substantial innovations have the ability to alter the competitive landscape of a particular market.
  
  
• Transformational Innovation:
  Transformational innovations are new products or systems that usually exceed the current market's needs. Transformational innovations have the ability to create new businesses and markets while, in some instances, destroying old ones.

The Egg Factory Scope:

The Company is diversified in its technological scope. However, more recently The Egg Factory has been focusing it's efforts on innovations within the fields of Optics and Ophthalmics. The Company challenges its business and technology experts to cross-fertilize ideas and to maximize each opportunity's value. Cross-fertilization involves taking technologies from one industry and applying those technologies to new applications in other industries. The Company believes that its broad scope allows it to both increase the value of its innovations by discovering multiple applications in different industries as well as identify new innovations.

Innovations currently under both development and/or investigation have applications in areas such as:

Hearing Healthcare (sold)	Nanotechnology
Optics (VC Funded)	Solar Power (VC Funded)
Ophthalmics	Agri-Technology (Sold)
Spectral Filtering	Meteorology
Vision Care (VC Funded)	Electronic Devices
Consumer Products	Industrial/Commercial Products
Nutritional Supplements (JV)